Key statistics
As of last trade Genfit SA (XUP:FRA) traded at 6.19, -2.06% below its 52-week high of 6.32, set on Feb 04, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.19 |
|---|---|
| High | 6.19 |
| Low | 6.19 |
| Bid | 6.50 |
| Offer | 6.57 |
| Previous close | 6.18 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 50.04m |
| Free float | 43.46m |
| P/E (TTM) | -- |
| Market cap | 312.73m EUR |
| EPS (TTM) | -0.7737 EUR |
Data delayed at least 15 minutes, as of Feb 10 2026 07:06 GMT.
More ▼
- GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
- GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
- GENFIT Announces 2026 Financial Calendar
- GENFIT annonce son calendrier financier pour 2026
- GENFIT : Profil de sécurité favorable en Phase 1 et forte activité anti-inflammatoire pour G1090N, actif clé dans l’ACLF
- GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N
- GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
- GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique
- GENFIT annonce la nomination d’un nouveau Directeur Médical
- GENFIT Announces Appointment of new Chief Medical Officer
More ▼
